Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy

Hospital Universitario Virgen de la Arrixaca60 enrolled

Overview

This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence of seroma after axillary lymphadenectomy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

TRIPLE

Enrollment

Conditions

Seroma

Interventions

Standard axillary lymphadenectomyPROCEDURE

Standard axillary lymphadenectomy

Collagen sponge coated with human coagulation factorsPROCEDURE

Three patches of collagen sponge coated with human coagulation factors (TachoSil®, Nycomed Pharma, AS) were perpendicularly placed at the end of lymphadenectomy on the axillary neurovascular bundle, thoracodorsal pedicle, and costal wall, covering the axillary walls

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with axillary lymphadenectomies performed for oncological conditions. Exclusion Criteria: * Patients that did not want to participate in the study.

Locations (1)

Hospital Universitario "Virgen de la Arrixaca"

Murcia, Murcia, Spain

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.